MedPath

Pimozide

Generic Name
Pimozide
Brand Names
Orap
Drug Type
Small Molecule
Chemical Formula
C28H29F2N3O
CAS Number
2062-78-4
Unique Ingredient Identifier
1HIZ4DL86F

Overview

A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to haloperidol for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)

Indication

适用于急、慢性精神分裂症,对精神分裂症的阴性症状疗效较好,亦可用于治疗偏执状态、亨廷顿病、抽动秽语综合征、躁狂症、神经性厌食、青少年行为障碍等。

Associated Conditions

  • Delusional Parasitosis
  • Tics

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Par Pharmaceutical, Inc.
49884-347
ORAL
1 mg in 1 1
11/25/2017
Par Pharmaceutical, Inc.
49884-348
ORAL
2 mg in 1 1
11/25/2017

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
ORAP TAB 10MG
mcneil pharmaceutical, division of ortho-mcneil inc.
00573817
Tablet - Oral
10 MG / TAB
12/31/1983
PMS-PIMOZIDE
02239829
Tablet - Oral
2 MG
10/18/2002
ORAP
aa pharma inc
00313823
Tablet - Oral
4 MG
12/31/1975
PIMOZIDE
aa pharma inc
02245432
Tablet - Oral
2 MG
4/1/2003
ORAP
aa pharma inc
00313815
Tablet - Oral
2 MG
12/31/1975
PIMOZIDE
aa pharma inc
02245433
Tablet - Oral
4 MG
4/1/2003
PMS-PIMOZIDE
02239830
Tablet - Oral
4 MG
10/18/2002
PMS-PIMOZIDE
02239831
Tablet - Oral
10 MG
N/A

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
ORAP FUERTE 4 mg COMPRIMIDOS
Eumedica.
49504
COMPRIMIDO
Medicamento Sujeto A Prescripción Médica
Commercialized
ORAP 1 mg COMPRIMIDOS
Eumedica.
49503
COMPRIMIDO
Medicamento Sujeto A Prescripción Médica
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.